[Commentary on] Tamoxifen in the treatment of advanced or recurrent endometrial carcinoma: A Gynecologic Oncology Group (GOG) study Journal Article
| Author: | Sabbatini, P. |
| Article Title: | [Commentary on] Tamoxifen in the treatment of advanced or recurrent endometrial carcinoma: A Gynecologic Oncology Group (GOG) study |
| Keywords: | endometrial neoplasms -- drug therapy; tamoxifen -- therapeutic use; severity of illness; endometrial neoplasms -- prognosis; tamoxifen -- adverse effects |
| Journal Title: | Women's Oncology Review |
| Volume: | 1 |
| Issue: | 1 |
| ISSN: | 1473-3404 |
| Publisher: | Taylor & Francis Group |
| Date Published: | 2001-01-01 |
| Start Page: | 74 |
| End Page: | 75 |
| Language: | English |
| ACCESSION: | 2004135409 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cin20 |
| DOI/URL: | |
| Notes: | Accession Number: 2004135409 -- Entry Date: 20040813 -- Revision Date: 20090313 -- Publication Type: journal article; abstract; commentary -- Original Study: Thigpen T, Brady MF, Homesley HD, Soper JT, Ball J -- Tamoxifen in the treatment of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group (GOG) study -- J CLIN ONCOL 2001; 19: 364-7 -- Journal Subset: Biomedical; Editorial Board Reviewed; Europe; Peer Reviewed; UK & Ireland -- NLM UID: 101128014. -- Source: cin20 |
MSK Authors
-
262Sabbatini